In a retrospective study including 76 patients with severe COVID-19, Tα1 treatment significantly reduced patient’s mortality (P < 0.05) and increased CD4+ and CD8+ T cell counts compared with the control group [109]. The gene discussed is TAAR1; the disease is COVID-19.